NCCN Guidelines for Patients® | Mantle Cell Lymphoma

64 NCCN Guidelines for Patients ® : Mantle Cell Lymphoma, 2017 Index Index biopsy 10, 14, 21, 23, 40, 43 blood tests 17, 23, 40, 43 chemotherapy 18, 27–30, 33, 35, 38, 42 clinical trial 33–35, 40–42, 43–45, 49 complementary and alternative medicine 33 complete blood count 16–17 comprehensive metabolic panel 16–17 computed tomography 16, 18–19, 23, 31, 38, 42 diagnosis 10–14, 21, 48 fertility 16, 23 immunohistochemistry 12–13 immunomodulators 26, 35 involved-site radiation therapy 31 lymphatic system 7–9, 14, 42 lymphocyte 8, 14 lymphoma 8–14, 16–18, 20–23, 25–26, 28–30, 33–35, 37–40, 44–45, 48, 53 medical history 15–17, 40–41, 43 NCCN Member Institutions 63 NCCN Panel Members 62 pathology report 14, 52 physical exam 16–17, 40–41, 43 positron emission tomography/computed tomography 16, 19, 23, 31, 38, 42 radiation therapy 31–32, 35, 38, 40–41, 44–45 stem cell transplant 33, 35, 39–40, 42–45 steroids 29, 35 supportive care 30, 38, 42, 45 targeted therapy 26, 30, 35

RkJQdWJsaXNoZXIy MTE3MTE1